These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2835729)

  • 1. A trans-acting factor represses the activity of the polyoma virus enhancer in undifferentiated embryonal carcinoma cells.
    Sassone-Corsi P; Fromental C; Chambon P
    Oncogene Res; 1987 Jul; 1(2):113-9. PubMed ID: 2835729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells.
    Couture LA; Lehman JM
    Int J Dev Biol; 1993 Mar; 37(1):125-33. PubMed ID: 8389574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition studies with repressors and activators of viral enhancer function in F9 mouse embryonal carcinoma cells.
    Sleigh MJ; Lockett TJ; Kelly J; Lewy D
    Nucleic Acids Res; 1987 May; 15(10):4307-24. PubMed ID: 3035489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    Feuer G; Taketo M; Hanecak RC; Fan H
    J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature dependent expression of polyoma virus in murine embryonal carcinoma cells.
    Dandolo L; Vasseur M; Kress C; Aghion J; Blangy D
    J Cell Physiol; 1980 Oct; 105(1):17-24. PubMed ID: 6253510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.
    Wasylyk B; Imler JL; Chatton B; Schatz C; Wasylyk C
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7952-6. PubMed ID: 2847148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.
    Herbomel P; Bourachot B; Yaniv M
    Cell; 1984 Dec; 39(3 Pt 2):653-62. PubMed ID: 6096017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of the interaction of polyoma virus and simian virus 40 with embryonal carcinoma cells.
    Hales K; Lehman JM
    Exp Mol Pathol; 1987 Aug; 47(1):48-58. PubMed ID: 3038593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription.
    DePolo NJ; Villarreal LP
    J Virol; 1991 Jun; 65(6):2921-8. PubMed ID: 1851864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the regulatory region of polyoma mutant F9-1 DNA.
    Böhnlein E; Chowdhury K; Gruss P
    Nucleic Acids Res; 1985 Jul; 13(13):4789-809. PubMed ID: 2991846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of polyoma virus transcription in murine embryonal carcinoma cells.
    Dandolo L; Blangy D; Kamen R
    J Virol; 1983 Jul; 47(1):55-64. PubMed ID: 6306281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the individual enhancer core sequences of polyomavirus: cell-specific uncoupling of DNA replication from transcription.
    Campbell BA; Villarreal LP
    Mol Cell Biol; 1988 May; 8(5):1993-2004. PubMed ID: 2838739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells.
    Fujimura FK; Linney E
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1479-83. PubMed ID: 6280185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.